Approval · Notice of Compliance 10090 · 2009

METADOL: Notice of Compliance 10090

Issued March 13, 2009

A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.

Notice number: 10090
Date: March 13, 2009
Company: Paladin Labs Inc
Product type: Prescription Pharmaceutical
Submission: New Drug Submission (NDS)
Submission class: Admin
Reason: Manufacturer name change
Therapeutic class: Opioid analgesic

Products in this notice

Brand	DIN	Status today
METADOL	02247694	Marketed
METADOL	02241377	Marketed
METADOL	02247698	Marketed
METADOL	02247699	Marketed
METADOL	02247700	Marketed
METADOL	02247701	Marketed

Medicinal ingredients

METHADONE HYDROCHLORIDE 1 MG per ML
METHADONE HYDROCHLORIDE 10 MG per ML
METHADONE HYDROCHLORIDE 1 MG per TAB
METHADONE HYDROCHLORIDE 5 MG per TAB
METHADONE HYDROCHLORIDE 10 MG per TAB
METHADONE HYDROCHLORIDE 25 MG per TAB